🔬 Free shipping on orders over $150 · 99%+ purity verified · Lab-tested peptides

Liver Bioregulator Research: Hepatocyte Peptide Studies

NLP Research Team 10 min read
Classic hepatic lobule cross-section: hexagonal lobule architecture with portal triads at six corners (each showing portal vein branch, hepatic artery branch, and bile duct in cross-section), hepatocyte plates radiating toward the central vein at lobule center, sinusoidal spaces with Kupffer cells labeled, hepatocyte visible nucleus and endoplasmic reticulum. Zone 1/2/3 metabolic gradient labeled from periportal to centrilobular. Navy outlines, electric blue for zone gradient.

Last updated: July 2026

A liver bioregulator is a short peptide studied for effects on hepatocyte gene activity. The liver is a large organ. It filters blood, makes proteins, stores energy, and removes waste. Hepatocytes (liver cells) do most of this work. They respond to chemical signals in the blood. According to Seiwerth et al. (2017) (PMID 28087487), BPC-157 reduced inflammatory gene markers in gastrointestinal and organ cell models. Liver cell markers were also tracked in some models. All cited data come from cell and animal studies.

Next Level Pharm is a US-based supplier of research-grade peptides. BPC-157, AICAR, and SS-31 are available as COA-verified research compounds. Each lot is tested to ≥99% purity by HPLC and mass spec. The average purity across the last 100 batches is 99.4%.

These research compounds are not approved drugs. They are studied only in cell and animal models. All findings cited here come from such models.

Key Takeaways

  1. Hepatocytes Are the Main Liver Cell Type: Hepatocytes make up about 80 percent of the liver by volume. They process nutrients, make albumin and clotting proteins, and remove toxins from blood.
  2. BPC-157 Is Studied for Inflammatory Markers: BPC-157 is a 15-amino acid peptide. It has been studied for effects on inflammatory gene markers in liver and GI cell models.
  3. AICAR Activates AMPK in Hepatocytes: AICAR (5-aminoimidazole-4-carboxamide ribonucleoside) is a cell-permeable compound. It activates AMPK (adenosine monophosphate kinase), an energy-sensing enzyme in hepatocytes.
  4. SS-31 Targets Mitochondria in Liver Cells: SS-31 is a 4-amino acid peptide. It targets cardiolipin, a lipid in the inner mitochondrial membrane. Hepatocytes need large amounts of ATP for liver function.
  5. All Findings Come from Cell and Animal Models: Human clinical data have not been established. These compounds are for lab research use only.

Researchers use these compounds to study hepatocyte gene activity in cell and animal models. The results guide further liver biology research.

What Are Liver Bioregulators?

A liver bioregulator is a compound studied for effects on hepatocyte gene activity in cell models. These compounds are tested in hepatocyte cell lines and animal models. They are not approved drugs.

The liver has several functions. It filters blood from the gut before it reaches the rest of the body. It makes proteins like albumin and clotting factors. It stores glucose as glycogen. It removes waste products and drugs from blood.

Hepatocytes carry out most of these tasks. They have high energy needs. Each hepatocyte has hundreds of mitochondria (energy-making organelles). Hepatocyte cell lines like HepG2 and Huh-7 are used in liver peptide research.

What Is BPC-157 and How Is It Studied in Liver Models?

BPC-157 is a 15-amino acid peptide. Its sequence comes from a region of gastric juice protein. In cell models, BPC-157 has been studied for effects on inflammatory markers in multiple tissue types, including liver cells.

In liver research, BPC-157 is studied for changes in NF-kB (nuclear factor kappa B) activity. NF-kB is a gene switch. When active, it turns on genes that make inflammatory proteins. Scientists measure NF-kB activity before and after BPC-157 exposure in hepatocyte cells.

Some animal models track liver enzyme levels (ALT and AST) after BPC-157 exposure. High ALT and AST are markers of liver cell stress in animal injury models. Results from treated groups were compared to control groups. These are in vitro and animal model findings only.

BPC-157 is available at Next Level Pharm as a COA-verified research compound. Every lot is tested by HPLC and mass spec. Each vial ships with a COA and lot number.

What Is AICAR and How Does It Work?

AICAR stands for 5-aminoimidazole-4-carboxamide ribonucleoside. It is a cell-permeable nucleotide analog. Inside cells, it becomes AICAR monophosphate (ZMP). ZMP mimics AMP, a low-energy signal molecule. This activates AMPK (adenosine monophosphate kinase), an energy sensor.

AMPK is found in hepatocytes and many other cell types. When AMPK is active, it shifts how the cell uses glucose and fat. In hepatocyte models, AMPK activation changed markers of glucose output and fat processing.

According to Corton JM et al. (1995) (PMID 7733185), AICAR activated AMPK in multiple cell types. This established AICAR as a research tool for studying AMPK biology in cell models. These are in vitro findings only.

AICAR is available as a COA-verified research compound. Every lot is tested to ≥99% purity. Each vial ships with a COA and lot number.

HepG2 cell model hepatocyte enzyme assay bar chart: three paired bars — ALT activity (U/L), AST activity (U/L), and GSH level (nmol/mg protein) — each showing vehicle control (gray) vs peptide-treated (electric blue). Reference range band shown for ALT and AST. Labeled axes, p-value annotation, navy/blue palette, minimal grid lines.

What Is SS-31 and How Is It Studied in Hepatocytes?

SS-31 (Szeto-Schiller 31) is a 4-amino acid peptide. Its sequence is D-Arg-Dmt-Lys-Phe-NH2. It enters cells and targets the inner membrane of mitochondria (the energy-making organelles). Hepatocytes have very high energy needs. They use ATP for protein production, detox, and nutrient processing.

The inner mitochondrial membrane holds cardiolipin, a lipid that organizes the energy-making proteins. When cardiolipin breaks down, energy output drops. SS-31 is studied for effects on cardiolipin integrity and ATP production in cell models.

According to Szeto HH et al. (2014) (PMID 24449843), SS-31 preserved mitochondrial function in cell models under metabolic stress. Cardiolipin integrity markers improved in treated cells. ATP production also rose in treated vs. control groups. These are in vitro and animal model findings only.

SS-31 is available at Next Level Pharm as a COA-verified research compound. Every lot is tested to ≥99% purity. Each vial ships with a COA and lot number.

How Do Liver Peptides Differ From Approved Drugs?

Approved liver drugs have completed human clinical trials. They have known safety and dosing profiles. Examples include antiviral drugs for hepatitis B and C, and drugs for liver inflammation.

Liver research peptides have not completed human clinical trials. They are studied in cell and animal models only. They target different steps in liver cell biology. BPC-157 targets NF-kB inflammation. AICAR targets AMPK energy sensing. SS-31 targets mitochondrial cardiolipin.

Each pathway is tracked with specific lab assays. NF-kB assays use reporter gene kits. AMPK assays measure phosphorylation of downstream proteins. Mitochondrial assays track ATP and cardiolipin levels.

Feature Approved Liver Drug Liver Research Compound
Clinical status FDA-approved Research-stage (cell/animal models only)
Study model Human clinical trials Cell assay, animal model
Key target Established liver pathway Gene expression or mitochondria
Purity standard Pharmaceutical-grade ≥99% HPLC + mass spec
Availability Prescription pharmacy Research compound supplier
Application Clinical care Lab research only

Frequently Asked Questions

What Are Liver Bioregulators?

Liver bioregulators are compounds studied in cell and animal models for effects on hepatocyte gene activity. Key examples include BPC-157 (15-amino acid, NF-kB inflammatory markers), AICAR (AMPK activator, metabolic markers), and SS-31 (mitochondrial cardiolipin pathway). Each targets a distinct step in liver cell biology. All data come from cell and animal studies. These compounds are for lab research use only. They are not approved drugs.

What Is a Hepatocyte?

A hepatocyte is the main liver cell type. Hepatocytes make up about 80 percent of the liver by volume. They process nutrients absorbed from the gut. They make proteins like albumin and clotting factors. They store glucose as glycogen. They remove waste from blood. Hepatocytes have high energy needs. Each cell has hundreds of mitochondria. Peptide research uses hepatocyte cell lines (HepG2, Huh-7) to study gene activity changes in liver cell models.

What Is BPC-157?

BPC-157 is a 15-amino acid peptide. Its sequence comes from gastric juice protein. In cell models, it is studied for effects on NF-kB and inflammatory gene markers. Scientists measure NF-kB activity and cytokine gene expression after BPC-157 exposure. Some animal models track liver enzyme markers (ALT, AST) after injury. Results are compared to control groups. All data come from cell and animal models. BPC-157 is for lab research use only.

What Is AICAR?

AICAR (5-aminoimidazole-4-carboxamide ribonucleoside) is a cell-permeable compound. Inside cells, it becomes ZMP, which mimics AMP and activates AMPK. AMPK is an energy-sensing enzyme. When active, it shifts how cells use glucose and fat. In hepatocyte cell models, AMPK activation changed markers of glucose output and fat metabolism. AICAR is used in research as a tool to study AMPK biology. All data come from cell and animal models. For lab research use only.

What Is AMPK?

AMPK (adenosine monophosphate kinase) is an energy sensor enzyme inside cells. It detects low energy states by sensing rising AMP levels. When active, AMPK turns on fat burning and glucose uptake while reducing fat production. In hepatocytes, AMPK is a key regulator of metabolic gene activity. AICAR activates AMPK by mimicking AMP. Scientists study AMPK activation as a marker of metabolic state changes in hepatocyte cell models.

What Is Cardiolipin?

Cardiolipin is a lipid found only in the inner membrane of mitochondria. It holds the energy-making proteins in place so they can produce ATP. When cardiolipin breaks down, energy output drops and cell stress markers rise. Hepatocytes have many mitochondria and depend on high ATP output. SS-31 is studied for effects on cardiolipin integrity in hepatocyte cell models. Better cardiolipin markers are tracked as a study outcome. All data come from in vitro models.

What Is NF-kB?

NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells) is a gene switch inside cells. When active, it turns on genes that make inflammatory proteins. In hepatocytes, NF-kB is activated by stress signals from the blood. Active NF-kB leads to higher inflammatory protein output. BPC-157 is studied for effects on NF-kB activity in liver cell models. Scientists use reporter gene kits to measure NF-kB changes. All data come from in vitro studies.

What Cell Lines Are Used in Liver Research?

Common cell lines include HepG2 cells (human hepatocellular carcinoma cells used as a liver model) and Huh-7 cells (human liver cells). Both express liver-specific enzymes and are used to measure NF-kB activity, AMPK phosphorylation, and mitochondrial function. Animal models include rodent liver injury models for ALT and AST tracking. Scientists expose cells to the test compound and measure gene and protein markers by ELISA and Western blot.

Are These Compounds Synthetic?

Yes. Research-grade BPC-157 (15 amino acids), AICAR (nucleotide analog), and SS-31 (4 amino acids) are all lab-synthesized. Synthesis ensures exact sequences and consistent purity. It also removes the risk of biological contamination. Research-grade compounds must meet ≥99% HPLC purity standards. Mass spec confirms the molecular weight for every batch before shipping.

Are These Compounds Verified for Research Use?

Research-grade liver peptides are tested by HPLC and mass spec per batch. HPLC confirms ≥99% purity for the target compound peak. Mass spec confirms molecular weight matches the expected sequence. A COA with lot number is provided per batch. All compounds are for lab research use only and are not for clinical or personal use of any kind.

Summary

Liver bioregulators are compounds studied in cell and animal models for effects on hepatocyte gene activity. Key compounds include BPC-157 (NF-kB inflammatory markers in liver and GI cell models) and AICAR (AMPK activation in hepatocytes). SS-31 targets the mitochondrial cardiolipin pathway in liver cells.

Hepatocytes have high energy demands and are a key research target. Anti-inflammatory and metabolic compounds are studied for gene marker changes in liver cell models. All cited findings come from cell and animal research. These compounds are for lab research use only.

What Should You Do Next?

Researchers studying liver and hepatocyte cell biology should source verified compounds for lab protocols. Before any study, confirm HPLC purity is ≥99% and mass spec matches the expected molecular weight. Record the lot number from the COA for batch traceability.

Shop research peptides. BPC-157, AICAR, and SS-31 are available with HPLC and mass spec data on every COA.

People Also Read

About the Author

Next Level Pharm Research Team

Alex M covers peer-reviewed findings in peptide science for Next Level Pharm, a US-based supplier of research-grade peptides verified to ≥99% purity via HPLC and mass spectrometry on every batch.

 

Disclaimer: The information provided on this page is for educational and research purposes only. Next Level Pharm products are intended for laboratory research use only. They are not intended for human consumption, diagnostic, therapeutic, or medicinal purposes. This content does not constitute medical advice. Always consult a licensed healthcare professional before making any health-related decisions.